Literature DB >> 2429625

Selection of operation for esophageal cancer based on staging.

D B Skinner, A G Little, M K Ferguson, A Soriano, V M Staszak.   

Abstract

The concept of en bloc removal of tissue surrounding the esophagus was applied to intrathoracic esophageal cancers, and the first 80 cases were operated on by this technique between 1969 and 1981. Analysis of prognostic factors showed that only penetration through the esophageal wall and lymph node spread influenced survival. Since 1981, a new staging system based on wall penetration (W) and lymph nodes (N), as well as systemic metastases (M), and similar to the modified Dukes' system for colon cancer has been used to select patients before and during surgery for en bloc resection if favorable pathology (W1, N0, or N1) could be anticipated. When curative resection was not attainable, based on preoperative and operative staging, a standard esophagectomy was considered for relief of symptoms when necessary. From July 1981 to June 1984, 68 esophageal cancers were referred to us, and 31 were resected by the en bloc method, 21 by standard esophagectomy, and 16 were not resected. The success of preoperative staging was confirmed, as only nine of the 31 en bloc cases demonstrated both W2 and N2 pathology. The proportion of W2N2 cases subjected to en bloc esophagectomy was less (p less than 0.01) than that in the preceding series. This selection of cases showed a favorable deviation in the survival curve following en bloc esophagectomy since 1981 compared to the earlier interval. Patients treated by en bloc esophagectomy had a significantly greater survival than they did following standard esophagectomy at all time intervals after 6 months. There was no difference in hospital mortality or complications between the two operations. Further evidence for the value of the new staging system was shown by the significant difference in survival curves between those with favorable versus unfavorable staging and treated by en bloc esophagectomy. Among all cases resected between 1981 and 1984, 18-month survival in W1 stage was 67% compared to 35% for W2 disease. Survival with N0 disease was 58% versus 43% for N1 stage and 21% for N2 stage. The favorable survival rates after en bloc resection in those with limited (less than W2N2) disease support the concept of selecting patients for curative surgery based on preoperative and operative staging. Preoperative radiation therapy caused a significant decline in patient survival at 6 and 12 months and has been abandoned.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 2429625      PMCID: PMC1251306          DOI: 10.1097/00000658-198610000-00007

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  8 in total

1.  THE SURGICAL TREATMENT OF CARCINOMA OF THE ESOPHAGUS AND CARDIA.

Authors:  A LOGAN
Journal:  J Thorac Cardiovasc Surg       Date:  1963-08       Impact factor: 5.209

2.  An exclusive right thoracic approach for cancer of the middle third of the esophagus.

Authors:  R Belsey; C A Hiebert
Journal:  Ann Thorac Surg       Date:  1974-07       Impact factor: 4.330

3.  The esophageal axis and its relationship to the resectability of carcinoma of the esophagus.

Authors:  H Akiyama; T Kogure; Y Itai
Journal:  Ann Surg       Date:  1972-07       Impact factor: 12.969

4.  Prognostic factors in carcinoma of the colon and rectum.

Authors:  E M Copeland; L D Miller; R S Jones
Journal:  Am J Surg       Date:  1968-12       Impact factor: 2.565

5.  Palliative procedures for esophageal cancer.

Authors:  M B Orringer
Journal:  Surg Clin North Am       Date:  1983-08       Impact factor: 2.741

6.  Barrett's esophagus. Comparison of benign and malignant cases.

Authors:  D B Skinner; B C Walther; R H Riddell; H Schmidt; C Iascone; T R DeMeester
Journal:  Ann Surg       Date:  1983-10       Impact factor: 12.969

7.  En bloc resection for neoplasms of the esophagus and cardia.

Authors:  D B Skinner
Journal:  J Thorac Cardiovasc Surg       Date:  1983-01       Impact factor: 5.209

8.  Potentially curable cancer of the esophagus.

Authors:  D B Skinner; K D Dowlatshahi; T R DeMeester
Journal:  Cancer       Date:  1982-12-01       Impact factor: 6.860

  8 in total
  47 in total

1.  Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years.

Authors:  N Ando; S Ozawa; Y Kitagawa; Y Shinozawa; M Kitajima
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

3.  [Resection of esophageal cancer without thoracotomy by manual dissection and eversion stripping].

Authors:  J M Müller; U Zieren; A S Jerke; C Jacobi; M Adili; H Pichlmaier
Journal:  Langenbecks Arch Chir       Date:  1992

Review 4.  Preoperative staging of gastrointestinal tumors by endosonography.

Authors:  K Ziegler; C Sanft; M Zeitz; E O Riecken
Journal:  Surg Endosc       Date:  1990       Impact factor: 4.584

5.  A novel approach to cancer staging: application to esophageal cancer.

Authors:  Hemant Ishwaran; Eugene H Blackstone; Carolyn Apperson-Hansen; Thomas W Rice
Journal:  Biostatistics       Date:  2009-06-05       Impact factor: 5.899

6.  Surgical treatment of carcinoma of the oesophagus.

Authors:  R Hurt
Journal:  Thorax       Date:  1991-07       Impact factor: 9.139

7.  Transhiatal esophagectomy for esophageal carcinoma in Turkey: with special reference to respiratory function.

Authors:  A Andican; S Perek; M F Ozçelik; A Perek
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

8.  Surgical management of esophageal cancer. A decade of change.

Authors:  J S Bolton; J L Ochsner; A A Abdoh
Journal:  Ann Surg       Date:  1994-05       Impact factor: 12.969

9.  Tumor spread in superficial esophageal cancer: histopathologic basis for rational surgical treatment.

Authors:  T Nishimaki; O Tanaka; T Suzuki; K Aizawa; H Watanabe; T Muto
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

10.  Prediction of hematogenous recurrence in patients with esophageal carcinoma.

Authors:  Hiroyuki Kato; Tatsuya Miyazaki; Masanobu Nakajima; Makoto Sohda; Yasuyuki Fukai; Norihiro Masuda; Minoru Fukuchi; Ryokuhei Manda; Katsuhiko Tsukada; Hiroyuki Kuwano
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.